Welcome

We invite you to join us for the first-ever ULACNet and CASCADE Virtual Poster Session! The virtual poster session will be held on December 5th, 2024 from 10am-12pm ET (check your local time zone here). You will be able to view the posters and interact live with other participants using video and audio during this time.

This platform provides an excellent opportunity to share and learn from each other about activities across both networks. We encourage posters about scientific results as well as programmatic, operational, or other aspects of on-going network activities. Submit your poster under the Poster Submission tab.

During and after the poster session, the materials will remain online for registered participants to continue viewing and interacting with comments. You may also send a message to the presenter to connect.

The US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet) focuses on developing evidence to improve and optimize approaches for prevention of human papillomavirus (HPV)-related cancers in people living with human immunodeficiency virus (HIV) infection.

The HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (CASCADE) conducts pragmatic clinical trials evaluating the clinical effectiveness of prevention interventions in intended-use settings with a goal to optimize the cervical cancer screening, management, and pre-cancer treatment cascade for women living with HIV.

For questions, contact Emma Brofsky at Emma.Brofsky@nih.gov.